[
  {
    "ts": null,
    "headline": "FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced that it is monitoring a safety issue with Boston Scientific Corporation’s ENDOTAK RELIANCE defibrillation leads, which are used with implantable cardioverter-defibrillators to prevent sudden cardiac death. Earlier this year, the company sent a letter to […]",
    "url": "https://finnhub.io/api/news?id=a2a42c4077103289548c5e3fcfc38320d19b811e9caad4e7a1df3d473b008670",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755240688,
      "headline": "FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads",
      "id": 136368161,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced that it is monitoring a safety issue with Boston Scientific Corporation’s ENDOTAK RELIANCE defibrillation leads, which are used with implantable cardioverter-defibrillators to prevent sudden cardiac death. Earlier this year, the company sent a letter to […]",
      "url": "https://finnhub.io/api/news?id=a2a42c4077103289548c5e3fcfc38320d19b811e9caad4e7a1df3d473b008670"
    }
  },
  {
    "ts": null,
    "headline": "2 Reasons to Like BSX (and 1 Not So Much)",
    "summary": "Boston Scientific has been treading water for the past six months, recording a small loss of 1.2% while holding steady at $104.10. The stock also fell short of the S&P 500’s 5.5% gain during that period.",
    "url": "https://finnhub.io/api/news?id=86160ce8580209ead79112f29495008db7deefba3727502d0d8fcdea08ea28f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755230591,
      "headline": "2 Reasons to Like BSX (and 1 Not So Much)",
      "id": 136368162,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific has been treading water for the past six months, recording a small loss of 1.2% while holding steady at $104.10. The stock also fell short of the S&P 500’s 5.5% gain during that period.",
      "url": "https://finnhub.io/api/news?id=86160ce8580209ead79112f29495008db7deefba3727502d0d8fcdea08ea28f8"
    }
  }
]